Dose Escalation & Expansion Study of Oral VRx-3996 & Valganciclovir in Subjects With EBV+ Lymphoid Malignancies
Viracta Therapeutics, Inc.
Viracta Therapeutics, Inc.
Oncternal Therapeutics, Inc
Celgene
Celgene
Takeda
Incyte Corporation
Amgen Research (Munich) GmbH
Baylor College of Medicine